| Q1 revenue | $1.04B, +25% YoY | (CFO)(prepared) |
| Q1 EBITDA | $88.9M, +44% YoY | (CFO)(prepared) |
| Q1 EBITDA margin | 8.6%, +110 bps YoY | (CFO)(prepared) |
| E&M Q1 revenue | $835.1M, +29% YoY | (CFO)(prepared) |
| E&M Q1 EBITDA / margin | $75.3M / 9.0%, +140 bps YoY | (CFO)(prepared) |
| T&D Q1 revenue | $204.4M, +10.5% YoY | (CFO)(prepared) |
| T&D Q1 EBITDA / margin | $27.1M / 13.3%, +240 bps YoY | (CFO)(prepared) |
| Backlog | $3.68B, +20% YoY | (CFO)(prepared) |
| Q1 operating cash flow | $143.7M vs $7.1M prior year | (CFO)(prepared) |
| Q1 FCF | $131.9M vs -$8.1M prior year | (CFO)(prepared) |
| Q1 CapEx | $15.5M vs $18.5M prior year | (CFO)(prepared) |
| Cash / gross debt / credit availability | $275M / $281.2M / $222.8M | (CFO)(prepared) |
| Pro forma net leverage | ~0.5x as of Apr 2 | (CFO)(prepared) |
| 2026 revenue guidance | $4.3B–$4.4B | (CFO)(prepared) |
| 2026 EBITDA guidance | $345M–$360M | (CFO)(prepared) |
| 2026 EBITDA margin at guidance midpoint | 8.1% | (CFO)(prepared) |
| Legacy business balance-of-year EBITDA margin | ~8% | (CFO)(prepared) |
| SCNM 2025 revenue / EBITDA margin | $109M / high-teens | (CFO)(prepared) |